Mary Zupanc, MD
Mary Zupanc, MD is a professor in the Departments of Pediatrics and Neurology at the University of California-Irvine. She also serves as the Division Chief of Pediatric Neurology at UCI/Children’s Hospital of Orange County, Director of the Pediatric Comprehensive Epilepsy Program, and Program Director for the UCI Pediatric Neurology Residency Program.
Dr. Zupanc received her undergraduate degree in Zoology from the University of Wisconsin-Madison in 1974, then carried out a year of research in genetics in Los Angeles before entering UCLA medical school and completing her medical degree in 1979. She completed pediatric residency training at the University of Washington and Harbor–UCLA Medical Center and pediatric neurology training at the University of Wisconsin-Madison under the mentorship of Dr. Raymond Chun. She has subsequently been in the epilepsy divisions at the Mayo Clinic, Columbia University, the Medical College of Wisconsin, and most recently, University of California-Irvine, collaborating with colleagues to develop pediatric epilepsy programs.
Dr. Zupanc is board certified in Pediatrics, Neurology with special competency in Child Neurology, Clinical Neurophysiology, and Epilepsy. She has published articles on a variety of topics, including neonatal seizures, infantile spasms, pediatric epilepsy surgery, and the efficacy of felbamate in intractable pediatric epilepsy. Dr. Zupanc has also authored book chapters on pediatric epilepsy surgery and reproductive health in adolescent girls with epilepsy.
Dr. Zupanc has been a member of the Child Neurology Society and the American Epilepsy Society since the early 1980s. In 2016 she was elected by her colleagues to serve a two-year term on the Board of Directors as Councillor for the West. She has also been active in the American Epilepsy Society, serving as the co-chairperson for the Women with Epilepsy Special Interest Group and on the Nominating Committee. As a member of the Professors of Child Neurology for many years, she collaborated with others in the development of a formal pediatric neurology curriculum for residents. In addition, she has been active in the American Academy of Neurology and the American Board of Psychiatry and Neurology, including recent service on the ABPN Maintenance of Certification Committee and on the United Council of Neurological Subspecialties.
Ann Tilton, MD
Ann Tilton, MD is a Professor of Neurology and Pediatrics and Section Chair of Child Neurology at Louisiana State Health Science Center in New Orleans, Louisiana. She is director of the Rehabilitation Center at Children’s Hospital of New Orleans and director of the Comprehensive Spasticity Program. Special interests include neurorehabilitation, neuromuscular disorders, and clinical applications and research in novel uses of botulinum toxin and intrathecal baclofen in the care of children and young adults with abnormal tone.
Dr. Tilton has served on the executive committee of the Professors of Child Neurology and has been active in the national Child Neurology Society, serving on its board of directors as a Councillor for the South (1996-98), Secretary/Treasurer (2003-04), and President (2005-07). She is currently a member of the Board of Directors of the Child Neurology Foundation. Dr. Tilton has been involved in the American Academy of Neurology Board of Directors where she served as the treasurer of the American Academy of Neurology Institute. Residency education is one of her priorities and she served as a member and Vice Chair of the ACGME Neurology Residency Review Committee (RRC). She is currently the Chair of the American Board of Psychiatry and Neurology (ABPN). Her interest in children with disabilities extends to the American Academy of Pediatrics where she served on the national Council for Children with Disabilities. Additionally, she is a certified member of the American Society of Neurorehabilitation and has been active on the executive committee.
Dr. Tilton has published on numerous topics and has spoken nationally and internationally on child neurology, rehabilitation, and spasticity management.